# Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)

> **NCT05963568** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Northern California Institute of Research and Education** · enrollment: 680 (estimated)

## Conditions studied

- Stroke
- Medication Adherence

## Interventions

- **DRUG:** Polycap

## Key facts

- **NCT ID:** NCT05963568
- **Lead sponsor:** Northern California Institute of Research and Education
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 680 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05963568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05963568, "Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05963568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*